Buying an FDA-regulated facility: how to assess compliance risk

“Is the facility FDA compliant?” is too broad to answer from a certificate, registration entry, or a short tour. A useful acquisition review defines the legal entity, products, operations, locations, period, and transaction being assessed. It then states what the available evidence supports and what remains unresolved.

Separate different kinds of evidence

For medical devices, FDA explicitly says registration and listing do not denote approval, clearance, or authorization of the establishment or its devices. Review product authorizations and establishment obligations separately. Confirm the position for each product category rather than extending a device statement to every business model.

Public inspection classifications are another input. FDA explains the scope and limitations of its inspection database. A public-record search is not a complete current quality audit, and an old inspection outcome does not establish the state of a later operation.

Start with a targeted data room

• Product and activity inventory, relevant authorizations, and establishment records.
• Inspection correspondence, responses, commitments, and evidence of completed actions.
• Quality-system scope, deviations, complaints, CAPA, and management review evidence.
• Facility, utility, equipment, software, laboratory, and validation records relevant to the intended operation.
• Supplier agreements, outsourced work, original-data access, and change history.

Test a few complete evidence trails

Choose representative examples: a released lot, an unexpected result, a maintenance intervention, a complaint, and an important supplier change. Trace each from the original record to the decision and follow-up. Expand the review where a gap could affect other products or periods. This is a proposed diligence method, not a universal required sampling plan.

Write findings for the buyer’s decision

Distinguish verified facts, management representations, missing evidence, and professional judgments. Explain potential operational implications without inventing remediation costs or promising a transaction outcome. Coordinate quality findings with transaction counsel, engineering, environmental and safety specialists, and other relevant advisers.

Changing ownership may create product-specific filing or operational questions. Assess those before relying on uninterrupted operations after closing.

Official sources: device registration limitations and inspection classification database. Reviewed October 20, 2026.

Continue the facility planning cluster

New facility planning · Buying a regulated business · Quality data room · Startup readiness · Contract laboratory acquisition

Request a scoped facility review or customized team training.